2009
DOI: 10.1002/jso.21263
|View full text |Cite
|
Sign up to set email alerts
|

Central pancreatectomy for benign tumors of the neck and body of the pancreas: Report of eight cases

Abstract: Central pancreatectomy is a safe technique for benign tumors of the pancreatic neck and body, especially when the enucleation is very difficult.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

0
17
0
6

Year Published

2009
2009
2014
2014

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 13 publications
(23 citation statements)
references
References 13 publications
0
17
0
6
Order By: Relevance
“…However, these lesions are increasingly being treated by central pancreatectomy (CP) [1]. Even though DP can be performed with low mortality, its morbidity is high, particularly because of the possible need for splenectomy and the sacrifice of healthy pancreas, leading to postoperative immunosuppression or diabetes [2,3]. PD is also complicated by postoperative diabetes as well as its own intrinsic morbidity [3].…”
Section: Introductionmentioning
confidence: 99%
See 2 more Smart Citations
“…However, these lesions are increasingly being treated by central pancreatectomy (CP) [1]. Even though DP can be performed with low mortality, its morbidity is high, particularly because of the possible need for splenectomy and the sacrifice of healthy pancreas, leading to postoperative immunosuppression or diabetes [2,3]. PD is also complicated by postoperative diabetes as well as its own intrinsic morbidity [3].…”
Section: Introductionmentioning
confidence: 99%
“…Even though DP can be performed with low mortality, its morbidity is high, particularly because of the possible need for splenectomy and the sacrifice of healthy pancreas, leading to postoperative immunosuppression or diabetes [2,3]. PD is also complicated by postoperative diabetes as well as its own intrinsic morbidity [3]. However, indications for enucleation are limited, especially when tumor size is large, leaving CP as a logical alternative.…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…Since the first central pancreatectomy was reported in 1984 by Dagradi and Serio [16] in a patient with pancreatic insulinoma, >400 cases of central pancreatectomy have been reported taking into account the previously revised series [2,17] and the most recent published series [5,[18][19][20][21][22][23][24]. The reconstructive steps after central pancreatectomy are usually a (end-to-end, end-to-side, duct-to-mucosa, or side-to-side) pancreaticojejunostomy or a pancreaticogastrostomy with the distal pancreatic stump after closure of cephalic pancreatic stump and main duct.…”
Section: Discussionmentioning
confidence: 99%
“…Therefore, minimally invasive procedures play an increasing role in surgery, sparing the normal pancreatic parenchyma. In case of benign or border-line malignancy tumors middle pancreatectomies are performed more and more often (1)(2)(3)(4)(5)(6)(7)(8)(9)(10)(11)(12)(13)(14)(15)(16)(17).…”
mentioning
confidence: 99%